K Holtmaat, F E van Beek, L M A Wijnhoven, J A E Custers, E J Aukema, S E J Eerenstein, I M van Oort, J E M Werner, J A Wegdam, I L E Jansen-Engelen, I H J T de Hingh, S Verheul, D T van der Beek, G Wekking, I Steggerda, V M H Coupé, N Horevoorts, A M de Korte, C Lammens, B I Lissenberg-Witte, B H de Rooij, J B Prins, I M Verdonck-de Leeuw, F Jansen
{"title":"Efficacy and Budget Impact of a Tailored Psychological Intervention Program Targeting Cancer Patients With Adjustment Disorder: A Randomised Controlled Trial.","authors":"K Holtmaat, F E van Beek, L M A Wijnhoven, J A E Custers, E J Aukema, S E J Eerenstein, I M van Oort, J E M Werner, J A Wegdam, I L E Jansen-Engelen, I H J T de Hingh, S Verheul, D T van der Beek, G Wekking, I Steggerda, V M H Coupé, N Horevoorts, A M de Korte, C Lammens, B I Lissenberg-Witte, B H de Rooij, J B Prins, I M Verdonck-de Leeuw, F Jansen","doi":"10.1002/pon.70123","DOIUrl":"10.1002/pon.70123","url":null,"abstract":"<p><strong>Background: </strong>Evidence on the efficacy of psychological interventions targeting cancer patients diagnosed with an adjustment disorder is scarce.</p><p><strong>Aims: </strong>This study aimed to investigate the efficacy and budget impact of a tailored psychological intervention program (AD-program) targeting cancer patients with adjustment disorder (AD).</p><p><strong>Methods: </strong>Patients (n = 59) were randomised to the intervention or control group. The AD-program consisted of three modules: psychoeducation (1-4 sessions) and two additional modules (maximum of 6 sessions per module) provided when needed. The primary outcome was psychological distress (HADS). Secondary outcomes were mental adjustment to cancer (MAC) and health-related quality of life (EORTC QLQ-C30). Measures were completed at baseline and 3 and 6 months after randomisation. The budget impact analyses were based on the population size, the costs of the AD-program, and other costs potentially affected by the AD-program.</p><p><strong>Results: </strong>The mean psychological distress score in the intervention group (n = 33) decreased over time (M = 19.2 at T0, M = 15.6 at T6). This decrease was not significantly different from decrease in the control condition (n = 26, M = 17.5 at T0, M = 15.9 at T6, p > 0.05). Also, there were no significant differences between the two conditions on the secondary outcomes. The budget impact of the AD-program was estimated at 7-28 million euros per year (to treat 14,430 patients).</p><p><strong>Conclusions: </strong>The effect of the AD-program was not statistically significant in this RCT. Limitations include that this study was underpowered due to recruitment difficulties during the COVID-19 pandemic. More research on the efficacy and implementation of the AD-program is warranted.</p><p><strong>Trial registration: </strong>Netherlands Trial Register identifier: NL7763. Registered on 3 June 2019.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 3","pages":"e70123"},"PeriodicalIF":3.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jane Q Yap, Kirsten A Riggan, Ewan K Cobran, Michele Y Halyard, Sarah E James, Marion K Kelly, Daphne T Phillips, Megan A Allyse
{"title":"Psychological Safety in the Medical Care of Black Breast and Ovarian Cancer Patients and Families.","authors":"Jane Q Yap, Kirsten A Riggan, Ewan K Cobran, Michele Y Halyard, Sarah E James, Marion K Kelly, Daphne T Phillips, Megan A Allyse","doi":"10.1002/pon.70127","DOIUrl":"https://doi.org/10.1002/pon.70127","url":null,"abstract":"<p><strong>Background: </strong>Psychological safety is critical to early and continued engagement with healthcare providers, yet no studies have explored this concept in relationship to cancer care. Black/African American (\"Black\") individuals experience disparities in breast and ovarian cancer beyond what can be explained biologically.</p><p><strong>Aims: </strong>We explored factors influencing psychological safety among Black breast and ovarian cancer patients and their family members.</p><p><strong>Methods: </strong>Socioeconomically diverse patients with a personal diagnosis or family history of breast and/or ovarian cancer were invited to complete a semi-structured qualitative interview on their cancer and healthcare experiences between September 2020 and April 2021. Informed by principles of grounded theory, interview transcripts were qualitatively analyzed for thematic content related to psychological safety.</p><p><strong>Results: </strong>Black breast and ovarian cancer patients and their family members described personal and community experiences and structural components of the healthcare system that suggested they may receive differential cancer care due to their race, placing them on guard. This posture was mediated by several self-identified factors that added to or detracted from their comfort, including provider racial and gender concordance in healthcare, personalized care, and effective communication. The priorities and perceptions of care in participants receiving care in safety net clinics were more focused on what was feasible given resource limitations rather than what was ideally desired.</p><p><strong>Conclusions: </strong>Implementation of strategies to promote psychological safety with Black cancer patients may foster improved patient experiences, as well as encourage early screening, patient engagement, and treatment continuation.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 3","pages":"e70127"},"PeriodicalIF":3.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143670678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Olivia C Robinson, Suzanne H Richards, Emily Shoesmith, Simon Pini, Marie Fallon, Matthew R Mulvey
{"title":"Contextual Adaptation of a Complex Intervention for the Management of Cancer Pain in Oncology Outpatient Services: A Case Study Example of Applying the ADAPT Guidelines.","authors":"Olivia C Robinson, Suzanne H Richards, Emily Shoesmith, Simon Pini, Marie Fallon, Matthew R Mulvey","doi":"10.1002/pon.70132","DOIUrl":"10.1002/pon.70132","url":null,"abstract":"<p><strong>Objectives: </strong>Standardising pain assessment in oncology outpatient services (OOS) leads to improvements in patients' pain and quality of life. The Edinburgh Pain Assessment Tool (EPAT) is a standardised cancer pain management tool that has been implemented on inpatient oncology wards (the original setting). Routine use of EPAT reduced post-surgical pain in cancer patients (the original scenario) and led to more appropriate analgesic prescribing. We describe here a case study of adapting the EPAT intervention for use in tertiary OOS in the United Kingdom (UK) National Health Services (NHS), using the ADAPT guidelines.</p><p><strong>Methods: </strong>The adaptation process followed Moore et al.'s ADAPT guidance: Step 1: We assessed rationale for adapting EPAT by reviewing existing literature of pain management in OOS. Step 2: Semi-structured interviews with 20-healthcare professionals (HCPs) to understand current practice and how the intervention might fit the new context (OOS). Step 3: Identified the 'core' and 'peripheral' components of EPAT, undertook four co-design workshops with 7-HCPs to reconfigure EPAT to fit OOS (adapted version is referred to as EPAT+). Four HCPs trialled the EPAT+ intervention in practice to refine the intervention.</p><p><strong>Results: </strong>Combining qualitative data from interviews with feedback from the co-design workshops and preliminary testing the prototype intervention highlighted several key adaptation goals for EPAT+. These included: (1) reduce length/time to complete EPAT+ due to time constraints in outpatient appointments, (2) the importance of pain re-assessment and using EPAT to facilitate patients to self-monitor their pain at home, and (3) the creation of new peripheral components to support communication with primary care providers.</p><p><strong>Conclusions: </strong>Using a theoretical driven conceptual guidance provided important learning on how to adapt an existing cancer pain management tool to a new setting (OOS). The result is a novel complex theory- and evidence-based intervention that will be formally tested in a cluster randomised pilot trial.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 3","pages":"e70132"},"PeriodicalIF":3.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11929535/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143693136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Systematic Review of Barriers to Breast Cancer Screening, and of Interventions Designed to Increase Participation, Among Women of Black African and Black Caribbean Descent in the UK.","authors":"Anietie E Aliu, Robert S Kerrison, Afrodita Marcu","doi":"10.1002/pon.70093","DOIUrl":"10.1002/pon.70093","url":null,"abstract":"<p><strong>Background: </strong>Compared with the general population, Black African and Black Caribbean women, living in the UK, are less likely to participate in breast cancer screening.</p><p><strong>Aims: </strong>The aims of this review were to: (1) systematically describe the barriers to breast cancer screening, experienced by women of Black African and Black Caribbean descent, living in the UK and (2) identify which barriers interventions attempting to reduce inequalities have targeted, and whether they have been effective at increasing participation in breast cancer screening, among women of Black African and Black Caribbean descent.</p><p><strong>Methods: </strong>We conducted a mixed-methods systematic review of primary research published in peer-reviewed journals. Seven databases were searched, yielding eight articles for inclusion in the review.</p><p><strong>Results: </strong>Barriers to breast cancer screening participation were categorised into six analytical themes: 'Understanding of, and concerns about, breast screening, the procedure and the reliability of test results', 'Misconceptions about, and lack of understanding of, the causes of breast cancer and personal risk', 'Emotional responses to cancer and screening', 'General barriers to accessing healthcare services (including breast screening)', 'Beliefs about cancer as a treatable disease' and 'Religious beliefs, cultural taboos and stigma'. These findings derive largely from studies with women who were not eligible for screening. Four studies testing interventions to promote uptake among ethnic minority groups were identified. None of them targeted Black African or Black Caribbean women, specifically; however, it was possible to extract data, for these groups, from the studies.</p><p><strong>Conclusion: </strong>Further research with women who are eligible for screening (but do not attend) is needed to verify the findings of this review. Studies targeting barriers experienced by Black women, particularly, are needed to reduce inequalities.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 2","pages":"e70093"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11786783/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143075111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lauren C Daniel, Margaret M Lubas, Huiqi Wang, Mariana Szklo-Coxe, Kirsten K Ness, AnnaLynn M Williams, Daniel A Mulrooney, Rebecca Howell, Wendy Leisenring, Yutaka Yasui, Leslie L Robison, Gregory T Armstrong, Eric J Chow, Kevin R Krull, Tara M Brinkman
{"title":"Frailty and Sleep in Adult Survivors of Childhood Cancer: A Childhood Cancer Survivor Study Report.","authors":"Lauren C Daniel, Margaret M Lubas, Huiqi Wang, Mariana Szklo-Coxe, Kirsten K Ness, AnnaLynn M Williams, Daniel A Mulrooney, Rebecca Howell, Wendy Leisenring, Yutaka Yasui, Leslie L Robison, Gregory T Armstrong, Eric J Chow, Kevin R Krull, Tara M Brinkman","doi":"10.1002/pon.70098","DOIUrl":"10.1002/pon.70098","url":null,"abstract":"<p><strong>Background: </strong>Young adult survivors of childhood cancer exhibit rates of frailty similar to adults several decades older without a cancer history. Frailty has been associated with sleep disturbances in non-cancer populations, but the relationship has not been examined in childhood cancer survivors who are known to exhibit elevated rates of sleep problems.</p><p><strong>Aims: </strong>Examine associations between frailty and poor sleep quality in long-term survivors of childhood cancer.</p><p><strong>Methods: </strong>This study utilized data from 9044 participants (> 5 years from diagnosis, M<sub>age</sub> = 40.8 years [SD = 9.5]) in the Childhood Cancer Survivor Study. Survivors' frailty status, chronic health conditions (CHC), health behaviors, mental health, and pain were collected in 2014-2016, and self-reported sleep quality in 2017-2019. Multivariable logistic regression models examined frailty status as a predictor of clinically significant poor sleep. All models were adjusted for age at diagnosis, age at survey, sex, race/ethnicity, smoking, risky/heavy alcohol use, and physical inactivity. Separate models included treatment-related variables, CHC burden (number/severity), and emotional health/pain as co-variates.</p><p><strong>Results: </strong>Frail survivors had 6-fold (95% CI 4.48-7.96) increased odds of future poor sleep quality. Little attenuation of this association was observed when accounting for cancer diagnosis (Odds Ratio [OR] 5.80, 95% CI 4.47-7.52), treatment exposures (OR 5.80, 95% CI 4.43-7.71), or chronic health condition burden (OR 5.12, 95% CI 3.98-6.59), but adjustment for emotional health/pain (OR 2.88, 95% CI 2.18-3.82) attenuated the association appreciably.</p><p><strong>Conclusions: </strong>Frail childhood cancer survivors have a higher prevalence of clinically significant poor sleep quality. Addressing poor physiologic reserve may impact sleep in frail childhood cancer survivors.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 2","pages":"e70098"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11807945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Susannah K Ayre, Elizabeth A Johnston, Michael Ireland, Sonja March, Jeff Dunn, Suzanne Chambers, Belinda C Goodwin
{"title":"Trajectories of Supportive Care Needs for People Who Travel to Receive Cancer Treatment: A Longitudinal Study in Australia.","authors":"Susannah K Ayre, Elizabeth A Johnston, Michael Ireland, Sonja March, Jeff Dunn, Suzanne Chambers, Belinda C Goodwin","doi":"10.1002/pon.70087","DOIUrl":"10.1002/pon.70087","url":null,"abstract":"<p><strong>Objective: </strong>To describe trajectories of change in unmet supportive care needs over a two-year period among people diagnosed with cancer and assess whether these trajectories vary as a function of sociodemographic and clinical characteristics.</p><p><strong>Methods: </strong>This analysis used data from a longitudinal study of people in Queensland, Australia who travelled largely from regional and remote areas to metropolitan centres to receive cancer care (N = 784). Supportive care needs were measured at baseline, then at 3-, 12-, and 24-month post-baseline across five domains ('psychological', 'physical and daily living', 'health systems and information', 'patient care and support', 'sexuality') using the Supportive Care Needs Survey-Short Form. Latent Curve Growth Analysis was performed to examine trajectories of change in unmet needs and assess whether these trajectories were influenced by participant characteristics.</p><p><strong>Results: </strong>Significant linear slopes indicated a modest decrease in unmet supportive care needs for all domains, except sexuality. For most domains, significant variance in intercepts but not slopes indicated individual differences in needs at baseline but not in trajectories over time. At baseline, the proportion of unmet needs was highest for the 'physical and daily living' (M = 44.2%, SD = 39.1%) and 'psychological' domains (M = 37.8%, SD = 36.3%). Unmet needs at baseline were consistently higher among participants who were younger, had a higher education level, and who reported poorer QoL.</p><p><strong>Conclusions: </strong>The proportion of unmet supportive care needs reported by people living with cancer may decrease over time, largely irrespective of sociodemographic and clinical characteristics. Despite this, unmet needs remain prevalent, particularly for physical and psychological support.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 2","pages":"e70087"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11811482/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mei Jun Tran, Michael Jefford, Tsien Fua, Ben Smith, Lachlan McDowell, Haryana M Dhillon, Fiona Lynch, Joanne Shaw, Alan White, David Wiesenfeld, Orla McNally, Maria Ftanou
{"title":"Feasibility and Acceptability of the Fear-Less Screening and Stratified-Care Model for Fear of Cancer Recurrence Among People Affected by Early-Stage Cancer.","authors":"Mei Jun Tran, Michael Jefford, Tsien Fua, Ben Smith, Lachlan McDowell, Haryana M Dhillon, Fiona Lynch, Joanne Shaw, Alan White, David Wiesenfeld, Orla McNally, Maria Ftanou","doi":"10.1002/pon.70070","DOIUrl":"10.1002/pon.70070","url":null,"abstract":"<p><strong>Objectives: </strong>Fear of cancer recurrence (FCR) is a prevalent unmet need for people affected by cancer, in the context of limited healthcare resources. Stratified-care models have potential to meet this need, while reducing resource demands. This study aimed to evaluate the feasibility and acceptability of screening procedures and interventions within the Fear-Less stratified-care model among those impacted by early-stage cancer.</p><p><strong>Methods: </strong>People affected by breast, head and neck, or gynaecological cancer, who had completed curative treatment, were screened for FCR. Individuals experiencing moderate FCR (scored 13-21 on the Fear of Cancer Recurrence Inventory-Short Form; FCRI-SF) were offered a purpose-developed clinician-guided self-management intervention, while those experiencing severe FCR (FCRI-SF score ≥ 22) were offered individual therapy (ConquerFear). Re-screening and evaluation measures were completed post-intervention.</p><p><strong>Results: </strong>Seventy-six (70%) of 109 eligible people completed screening, with 53/76 participating in the Fear-Less model evaluation. Thirty-nine of 53 participants reported FCR and were referred to an intervention; 30/39 (77%) accepted the referral. Fifteen (83%) of 18 participants completing the self-management intervention reported reading ≥ 75% of the resource at 5 weeks, with 10/18 (56%) reporting clinically meaningful (≥ 10%) reductions on the FCRI-SF post-intervention. Qualitative feedback indicated screening and the stratified-care received were acceptable.</p><p><strong>Conclusions: </strong>Screening procedures and interventions forming the Fear-Less model appear feasible and acceptable for identifying and treating FCR among people affected by early-stage cancer. Although further research is required to evaluate its efficacy, this model has the potential to meet a major unmet need, where psychosocial services are limited amid increased demand.</p><p><strong>Trial registration: </strong>This study was retrospectively registered on the Australian New Zealand Clinical Trials Registry (ACTRN12622000818730) on 10/6/2022.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 2","pages":"e70070"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11829655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143426054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aiche Sabah, Fethi Hammadi, Chiu-Hsiang Lee, Musheer A Aljaberi, Monique van Dijk, Chung-Ying Lin, Mark D Griffiths
{"title":"Post-Traumatic Stress Disorder (PTSD) Among Algerian Cancer Patients: Validity of the Arabic DSM-5 PTSD Checklist (PCL-5) and Associated Factors.","authors":"Aiche Sabah, Fethi Hammadi, Chiu-Hsiang Lee, Musheer A Aljaberi, Monique van Dijk, Chung-Ying Lin, Mark D Griffiths","doi":"10.1002/pon.70109","DOIUrl":"10.1002/pon.70109","url":null,"abstract":"<p><strong>Background: </strong>Cancer patients are at risk of post-traumatic stress disorder (PTSD) throughout their treatment journey due to serious challenges (e.g., complex surgical interventions, severe pain, and side effects from chemotherapy or radiation therapy). This may worsen patients' health and negatively impact their overall treatment journey and well-being. However, this area remains understudied in Algeria. Therefore, there is a need to understand the levels of PTSD symptoms and the associated factors among Algerian patients. To ensure accurate assessment and diagnosis, a validation study was conducted to confirm that the PTSD measurement instrument used was culturally appropriate for the Algerian context. The study's main objectives were to (i) determine the prevalence of PTSD among cancer patients in Algeria, (ii) validate the Arabic DSM-5 PTSD Checklist (PCL-5) among Algerian cancer patients, and (iii) explore the associations between demographic and clinical factors and PTSD among this population.</p><p><strong>Methods: </strong>The present study was cross-sectional and comprised 370 cancer patients. All participants were patients receiving treatment in oncology wards across various hospitals. All participants completed the PCL-5. Confirmatory factor analysis (CFA) was used to examine the factor structure of the PCL-5.</p><p><strong>Results: </strong>The PCL-5 was found to have a four-factor structure. Out of the 370 participants, 154 (41.6%) had PCL-5 scores below the cutoff of 31, indicating lower levels of PTSD symptoms; 216 participants (58.4%) had scores above this threshold, suggesting a likelihood of PTSD. Moreover, PTSD was significantly associated with patients' low educational attainment and more advanced stages of their disease.</p><p><strong>Conclusions: </strong>The findings indicated moderate to high PTSD symptoms among cancer patients in Algeria. Moreover, the Arabic PCL-5 demonstrated good psychometric properties confirming that it is a reliable and valid tool for assessing PTSD symptoms among Algerian cancer patients.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 2","pages":"e70109"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11845313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143472880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jani Lamarche, Rinat Nissim, Jonathan Avery, Jiahui Wong, Christine Maheu, Sylvie D Lambert, Andrea M Laizner, Jennifer Jones, Mary Jane Esplen, Sophie Lebel
{"title":"It is Time to Address Fear of Cancer Recurrence in Family Caregivers: Feasibility and Acceptability of a Randomized Pilot Study of the Family Caregiver Version of the Fear of Recurrence Therapy (FC-FORT).","authors":"Jani Lamarche, Rinat Nissim, Jonathan Avery, Jiahui Wong, Christine Maheu, Sylvie D Lambert, Andrea M Laizner, Jennifer Jones, Mary Jane Esplen, Sophie Lebel","doi":"10.1002/pon.70084","DOIUrl":"10.1002/pon.70084","url":null,"abstract":"<p><strong>Objective: </strong>Fear of cancer recurrence (FCR) is common, persistent, and associated with lower quality of life, impaired functioning, and psychological distress in family caregivers (FC) of individuals with a cancer diagnosis. Interventions are needed to specifically target FCR in FC. This study aimed to pilot test the adapted Family Caregiver-Fear Of Recurrence Therapy (FC-FORT) to establish its feasibility, acceptability, and clinical significance.</p><p><strong>Methods: </strong>This pilot study used a mixed-method, parallel, two-group randomized control trial (FC-FORT vs. waitlist control group) design. Women FC were recruited through Canadian hospitals, community partners, and social media. FC in the intervention group completed 7 weekly sessions of virtual group therapy (FC-FORT) and an exit interview. All participants completed questionnaires at baseline, post-intervention, and 3-month follow-up. Feasibility (e.g., recruitment, allocation, fidelity), acceptability (e.g., dropout, completion, satisfaction) and clinical significance of secondary outcomes were evaluated. Descriptive statistics, mixed ANOVAs, and conventional content analyses were used.</p><p><strong>Results: </strong>Regarding feasibility, 22 FC were recruited, 18 were randomized and therapist fidelity was 87%. As to acceptability, 67% of participants completed <math> <semantics><mrow><mo>≥</mo></mrow> <annotation>${ge} $</annotation></semantics> </math> 5 sessions (33% dropout). Questionnaire completion rate was 92%. FC satisfaction was 80%. Analyses did not reveal any significant differences on the secondary outcomes between groups. Qualitative analyses revealed high importance, helpfulness, satisfaction, and group cohesion. Suggestions were made by FC for improvements.</p><p><strong>Conclusions: </strong>This is one of the first interventions to address FCR in FC. While acceptability of FC-FORT was good, important feasibility issues need to be addressed before moving forward with a larger randomized control trial.</p><p><strong>Trial registration: </strong>NCT, NCT05441384. Registered July 1st, 2022, https://classic.</p><p><strong>Clinicaltrials: </strong>gov/ct2/show/NCT05441384.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 2","pages":"e70084"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11779570/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143067617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Predictors and Impact of Disclosure Efficacy Among Cancer Survivors.","authors":"Carolyn Rabin","doi":"10.1002/pon.70111","DOIUrl":"https://doi.org/10.1002/pon.70111","url":null,"abstract":"<p><strong>Background: </strong>Cancer survivors who disclose their cancer diagnosis and cancer-related experiences derive a variety of benefits including enhanced quality of life. Given this, it would be helpful to better understand the factors that facilitate disclosure among survivors. Disclosure efficacy-confidence that one can successfully execute a self-disclosure-may play a key role.</p><p><strong>Aims: </strong>In Study 1, survey data were analyzed to identify potential predictors of disclosure efficacy among cancer survivors and whether disclosure efficacy predicts intention to self-disclose in the future. In Study 2, a randomized, controlled design was used to evaluate whether psychoeducation about self-disclosure boosts disclosure efficacy.</p><p><strong>Methods: </strong>Data were analyzed from 181 cancer survivors who participated in a cross-sectional, online survey study (Study 1) and randomized controlled test of disclosure-related psychoeducational material (Study 2).</p><p><strong>Results: </strong>The results from Study 1 indicated that, as hypothesized, having engaged in more cancer-related disclosure in the past predicted higher levels of disclosure efficacy (though response to prior disclosures did not) and greater disclosure efficacy predicted greater intention to disclose again in the future. The results from Study 2 did not demonstrate that reading psychoeducational information on self-disclosure enhanced disclosure efficacy. However, exploratory analyses indicated that those receiving this information reported greater intention to engage in three of the four recommended, empirically based disclosure strategies.</p><p><strong>Conclusions: </strong>Findings underscore the role of disclosure efficacy in facilitating cancer-related disclosure among cancer survivors. Likewise, findings suggest the utility of developing interventions that enhance disclosure efficacy and provide opportunities for behavioral rehearsal of cancer-related disclosures.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 2","pages":"e70111"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}